Keppra (Levetiracetam) shows Promise Against Tremor: "Intention tremor (or cerebellar tremor) is a common symptom in MS patients. It is characterized by a slow, broad shaking that occurs at the end of an intended movement. Of course, this can have a major impact on quality of life.

A new study examined the effect of the oral anticonvulsant drug Levetiracetam (better known by its brand name of Keppra (r)) on 11 MS patients with intention tremor. Happily, administration of Keppra was associated with an improvement in both subjective and objective tests. Furthermore, the degree of improvement was not associated with the underlying multiple sclerosis disease severity or duration....)